Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
L-Glutamine wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
3 of 3 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
11 of 14 studies with measurable effects showed benefit.
Top outcomes
5-10g
Post-workout, Before bed, Or split throughout day
L-Glutamine powder
100-200mg daily
Morning with food, Can be divided into two doses
Pycnogenol (standardized extract)
2-4 weeks
2-4 weeks
1-2 weeks
4-8 weeks
6-12 weeks
4-8 weeks
Initial use
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
The New England journal of medicine (2018) · Rct · n=230
A total of 230 patients (age range, 5 to 58 years; 53.9% female) were randomly assigned, in a 2:1 ratio, to receive l-glutamine (152 patients) or placebo (78 patients).
What Is the Role of Nutritional Supplements in Support of Total Hip Replacement and Total Knee Replacement Surgeries? A Systematic Review
Nutrients (2018) · Systematic review
Amino acid supplementation is reported to reduce muscle atrophy and accelerate return of functional mobility.
Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies
Blood reviews (2025) · Systematic review · n=97
A pivotal phase III study of l-glutamine showed that patients treated with l-glutamine had a 25 % reduction in pain crises and 33 % fewer hospital days compared to placebo. l-glutamine was generally well tolerated with minimal side effects.
Phlebotonics for venous insufficiency
The Cochrane database of systematic reviews (2020) · Meta analysis · n=7690
Pooled data suggest that phlebotonics probably increase adverse events slightly, compared to placebo (RR 1.14, 95% CI 1.02 to 1.27; 37 studies; 5789 participants; moderate-certainty evidence).
Pine bark (Pinus spp.) extract for treating chronic disorders
The Cochrane database of systematic reviews (2020) · Meta analysis · n=1641
In a mixed group of participants with type 1 and type 2 DM we do not know whether pine bark extract decreases HbA1c (MD -0.20 %, 95% CI -1.83 to 1.43; one study; 67 participants; very low-certainty evidence).
Effect of pycnogenol supplementation on blood pressure: A systematic review and meta-analysis of clinical trials
Phytotherapy research : PTR (2020) · Meta analysis · n=922
Pooled analysis suggested that pycnogenol supplementation can reduced systolic blood pressure (SBP) of (-3.22 mmHg; 95% CI [-5.52, -0.92]) and diastolic blood pressure (DBP; -1.91 mmHg; 95% CI [-3.64, -0.18]).
Based on RCT showing reduced URTI incidence in combat athletes (n=21) and enhanced IgA levels. Limited sample size and specific population studied. Effect may be primarily in high-stress/training conditions.
Based on meta-analyses showing modest reductions in systolic (-3.22 mmHg) and diastolic (-1.91 mmHg) blood pressure. Effects are clinically small and studies show heterogeneity.
AI-estimated from published studies. Interpret as directional guidance.
L-Glutamine has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For reduce inflammation, L-Glutamine has a higher relevance score (85 vs 75).
No known interactions between L-Glutamine and Pine Bark Extract have been documented in our database. However, always consult a healthcare provider before combining supplements.